Day: May 22, 2023
TAGRISSO Plus Chemotherapy Shows Great Results In Clinical Trial For NSCLC
Tagrisso alone did not produce as much good result then TAGRISSO (osimertinib) plus chemotherapy did for patients with stage locally advanced or metastatic [...]